BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godyń J, Zaręba P, Łażewska D, Stary D, Reiner-Link D, Frank A, Latacz G, Mogilski S, Kaleta M, Doroz-Płonka A, Lubelska A, Honkisz-Orzechowska E, Olejarz-Maciej A, Handzlik J, Stark H, Kieć-Kononowicz K, Malawska B, Bajda M. Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease. Bioorg Chem 2021;114:105129. [PMID: 34217977 DOI: 10.1016/j.bioorg.2021.105129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong G, Guo J, Pang C, Su D, Tang C, Jing L, Zhang F, He P, Yan Y, Chen Z, Liu J, Jiang N. Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry 2023;130:106224. [DOI: 10.1016/j.bioorg.2022.106224] [Reference Citation Analysis]
2 Shi Z, Zou W, Zhu Z, Xiong Z, Li S, Dong P, Zhu Z. Tropane alkaloids (hyoscyamine, scopolamine and atropine) from genus Datura: extractions, contents, syntheses and effects. Industrial Crops and Products 2022;186:115283. [DOI: 10.1016/j.indcrop.2022.115283] [Reference Citation Analysis]